HRMY

Harmony Biosciences Holdings, Inc. Common Stock

40.28

USD

+0.68

+1.72%

Oct 09, 16:00 UTC -4

Closed

After-Market

40.16

-0.12

-0.31%

HRMY Earnings Reports

Positive Surprise Ratio

HRMY beat 16 of 24 last estimates.

67%

Next Report

Date of Next Report

Nov 03, 2026

Estimate for Q3 26 (Revenue/ EPS)

$280.04M

$1.17

Implied change from Q2 26 (Revenue/ EPS)

+7.18%

-8.59%

Implied change from Q3 25 (Revenue/ EPS)

+16.95%

+34.48%

Harmony Biosciences Holdings, Inc. Common Stock earnings per share and revenue

On Aug 04, 2026, HRMY reported earnings of 1.28 USD per share (EPS) for Q2 26, beating the estimate of 1.03 USD, resulting in a 23.30% surprise. Revenue reached 261.28 million, compared to an expected 255.17 million, with a 2.39% difference. The market reacted with a +8.93% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 8 analysts forecast an EPS of 1.17 USD, with revenue projected to reach 280.04 million USD, implying an decrease of -8.59% EPS, and increase of 7.18% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Inventiva S.A. - ADR

Report Date

Sep 28, 2026 For Q2 26

Estimate

-$0.37

Actual

-$0.25

Surprise

+33.55%

Palatin Technologies, Inc. Common Stock

Report Date

Sep 28, 2026 For Q4 26

Estimate

-$1.21

Actual

-$1.11

Surprise

+8.42%

FAQ

What were Harmony Biosciences Holdings, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Harmony Biosciences Holdings, Inc. Common Stock reported EPS of $1.28, beating estimates by 23.3%, and revenue of $261.28M, 2.39% above expectations.

How did the market react to Harmony Biosciences Holdings, Inc. Common Stock's Q2 2026 earnings?

The stock price moved up 8.93%, changed from $35.60 before the earnings release to $38.78 the day after.

When is Harmony Biosciences Holdings, Inc. Common Stock expected to report next?

The next earning report is scheduled for Nov 03, 2026.

What are the forecasts for Harmony Biosciences Holdings, Inc. Common Stock's next earnings report?

Based on 8 analysts, Harmony Biosciences Holdings, Inc. Common Stock is expected to report EPS of $1.17 and revenue of $280.04M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.